These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 2001536)
1. Stage IV neuroblastoma in infants. Long-term survival. Paul SR; Tarbell NJ; Korf B; Kretschmar CS; Lavally B; Grier HE Cancer; 1991 Mar; 67(6):1493-7. PubMed ID: 2001536 [TBL] [Abstract][Full Text] [Related]
2. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154 [TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience. Rosen EM; Cassady JR; Frantz CN; Kretschmar C; Levey R; Sallan SE J Clin Oncol; 1984 Jul; 2(7):719-32. PubMed ID: 6737018 [TBL] [Abstract][Full Text] [Related]
4. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology. Minard V; Hartmann O; Peyroulet MC; Michon J; Coze C; Defachelle AS; Lejars O; Perel Y; Bergeron C; Boutard P; Leverger G; Stephan JL; Thyss A; Chastagner P; Couillault G; Devalck C; Lutz P; Mechinaud F; Millot F; Plantaz D; Rialland X; Rubie H Br J Cancer; 2000 Oct; 83(8):973-9. PubMed ID: 10993641 [TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Franks LM; Bollen A; Seeger RC; Stram DO; Matthay KK Cancer; 1997 May; 79(10):2028-35. PubMed ID: 9149032 [TBL] [Abstract][Full Text] [Related]
6. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561 [TBL] [Abstract][Full Text] [Related]
7. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863 [TBL] [Abstract][Full Text] [Related]
8. Improved prognosis for infants with stage IV neuroblastoma. Kretschmar CS; Frantz CN; Rosen EM; Cassady JR; Levey R; Sallan SE J Clin Oncol; 1984 Jul; 2(7):799-803. PubMed ID: 6737020 [TBL] [Abstract][Full Text] [Related]
9. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification. Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726 [TBL] [Abstract][Full Text] [Related]
10. [MIBG scintigraphy in neuroblastoma: something more than an image]. Díez Jiménez L; Mitjavila Casanovas M Rev Esp Med Nucl; 2006; 25(2):118-43. PubMed ID: 16759621 [No Abstract] [Full Text] [Related]
11. The role of surgery in stage IV neuroblastoma. Castel V; Tovar JA; Costa E; Cuadros J; Ruiz A; Rollan V; Ruiz-Jimenez JI; Perez-Hernández R; Cañete A J Pediatr Surg; 2002 Nov; 37(11):1574-8. PubMed ID: 12407542 [TBL] [Abstract][Full Text] [Related]
12. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study. Fukuda M; Miyajima Y; Miyashita Y; Horibe K J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262 [TBL] [Abstract][Full Text] [Related]
13. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319 [TBL] [Abstract][Full Text] [Related]
14. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. De Bernardi B; Pianca C; Boni L; Brisigotti M; Carli M; Bagnulo S; Corciulo P; Mancini A; De Laurentis C; Di Tullio MT Cancer; 1992 Sep; 70(6):1625-33. PubMed ID: 1516016 [TBL] [Abstract][Full Text] [Related]
15. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study. Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959 [TBL] [Abstract][Full Text] [Related]
16. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715 [TBL] [Abstract][Full Text] [Related]
17. Age and prognosis in neuroblastoma. Review of 112 patients younger than 2 years. Jereb B; Bretsky SS; Vogel R; Helson L Am J Pediatr Hematol Oncol; 1984; 6(3):233-43. PubMed ID: 6517224 [TBL] [Abstract][Full Text] [Related]
18. [Hepatopathy in patients with stage 4S neuroblastoma]. Claviez A; Hero B; Schneppenheim R; Berthold F Klin Padiatr; 1996; 208(4):221-8. PubMed ID: 8926687 [TBL] [Abstract][Full Text] [Related]